A critical appraisal of intravenous fluids: From the physiological basis to clinical evidence

Nephrology Dialysis Transplantation

Volumn 30, Issue 2, 2015, Pages 178-187

  Severs, David ^a   Hoorn, Ewout J ^a   Rookmaaker, Maarten B ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

chloride; colloids; crystalloids; saline

Indexed keywords

ACETIC ACID PLUS GLUCONATE SODIUM PLUS MAGNESIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; ALBUMIN; CHLORIDE; DEXTRAN 40; GELATIN; GELATIN SUCCINATE; HARTMANN SOLUTION; HETASTARCH; HUMAN ALBUMIN; INFUSION FLUID; RINGER ACETATE; RINGER LACTATE SOLUTION; SODIUM; SODIUM CHLORIDE; STEROFUNDIN; ALBUMINOID; COLLOID; ISOTONIC SOLUTION;

ACUTE KIDNEY FAILURE; BLOOD CLOTTING; CHEMICAL COMPOSITION; CLINICAL STUDY; COLLOID; CRYSTALLOID; HEMODYNAMICS; HUMAN; HYPERCHLOREMIA; HYPERKALEMIA; HYPOVOLEMIC SHOCK; INTENSIVE CARE; KIDNEY TRANSPLANTATION; METABOLIC ACIDOSIS; NEPHROTOXICITY; NONHUMAN; OSMOLALITY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RESUSCITATION; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; ADMINISTRATION AND DOSAGE; CRITICAL ILLNESS; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; TRENDS;

ALBUMINS; COLLOIDS; CRITICAL ILLNESS; FLUID THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; ISOTONIC SOLUTIONS; PRACTICE GUIDELINES AS TOPIC; SODIUM CHLORIDE;

EID: 84922536854     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu005     Document Type: Review

References (117)

1. Latta TA. Malignant cholera. Documents communicated by the Central Board of Health, London, relative to the treatment of cholera by the copious injection of aqueous and saline fluids into the veins. Lancet 1832; 18: 274-280
2. Barsoum N, Kleeman C. Now and then, the history of parenteral fluid administration. Am J Nephrol 2002; 22: 284-289
3. Hartmann AF, Senn MJ. Studies in the metabolism of sodium r-lactate. I. Response of normal human subjects to the intravenous injection of sodium r-lactate. J Clin Invest 1932; 11: 327-335
4. Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr 2008; 27: 179-188
5. Lazarus-Barlow WS. On the initial rate of osmosis of blood-serum with reference to the composition of 'physiological saline solution' in mammals. J Physiol. 1896; 20: 145-157
6. Czerny A. Versuche uer Bluteindickung und ihre Folgen. Archiv fu Experimentelle Pathologie und Pharmakologie 1894; 34: 268-280
7. Hogan JJ. The intravenous use of colloidal (gelatin) solutions in shock. J Am Med Assoc 1915; LXIV: 721-726
8. Saddler JM, Horsey PJ. The new generation gelatins. A review of their history, manufacture and properties. Anaesthesia 1987; 42: 998-1004
9. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379-386
10. Hoste EA, DeWaele JJ, Gevaert SA et al. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-Analysis. Nephrol Dial Transplant. 2010; 25: 747-758
11. Pannu N, Wiebe N, Tonelli M, Alberta Kidney Disease Network. Prophylaxis strategies for contrast-induced nephropathy. J Am Med Assoc 2006; 295: 2765-2779
12. Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N Engl J Med 1992; 327: 718-724
13. Crowell JW, Houston B. Effect of acidity on blood coagulation. Am J Physiol 1961; 201: 379-382
14. Dunn EL, Moore EE, Breslich DJ et al. Acidosis-induced coagulopathy. Surg Forum 1979; 30: 471-473
15. Cosgriff N, Moore EE, Sauaia A et al. Predicting life-Threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 1997; 42: 857-861; discussion 861-862.
16. Meng ZH, Wolberg AS, Monroe DM, 3rd et al. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003; 55: 886-891
17. Engstrom M, Schott U, Romner B et al. Acidosis impairs the coagulation: a thromboelastographic study. J Trauma 2006; 61: 624-628
18. Kellum JA, Song M, Li J. Science review: extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care 2004; 8: 331-336
19. Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol 2001; 69: 522-530
20. Greger R. Units used in physiology and their definition. In: Greger R, Winhorst U (eds). Comprehensive Human Physiology From Cellular Mechanisms to Integration. Berlin: Springer, 1996, pp. 2421
21. Stuart J. Erythrocyte rheology. J Clin Pathol 1985; 38: 965-977
22. Weisberg HF. Osmotic pressure of the serum proteins. Ann Clin Lab Sci 1978; 8: 155-164
23. Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 2012; 108: 384-394
24. Adamson RH, Lenz JF, Zhang X et al. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 2004; 557: 889-907
25. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch 2000; 440: 653-666
26. Vink H, Duling BR. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol 2000; 278: H285-H289
27. Reitsma S, Slaaf DW, Vink H et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454: 345-359
28. Berg S, GolsterM, Lisander B. Albumin extravasation and tissuewashout of hyaluronan after plasma volume expansion with crystalloid or hypooncotic colloid solutions. Acta Anaesthesiol Scand 2002; 46: 166-172
29. Devaraj S, Yun JM, Adamson G et al. C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res 2009; 84: 479-484
30. Henry CB, Duling BR. TNF-Alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000; 279: H2815-H2823
31. Rehm M, Bruegger D, Christ F et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116: 1896-1906
32. Steppan J, Hofer S, Funke B et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalyx. J Surg Res 2011; 165: 136-141
33. Berg S, Engman A, Hesselvik JF et al. Crystalloid infusion increases plasma hyaluronan. Crit Care Med 1994; 22: 1563-1567
34. Levick JR. Capillary filtration-Absorption balance reconsidered in light of dynamic extravascular factors. Exp Physiol 1991; 76: 825-857
35. Kaye AD, Kucera IJ. Intravascular fluid and electrolyte physiology. In: Miller RD (ed). Miller's Anesthesia. Philadelphia: Churchill Livingstone, 2005, pp. 1763
36. Dubois MJ, Vincent JL. Colloid fluids. In: Hahn RG, Prough DS, Svensen CH (eds). Perioperative Fluid Therapy. New York:Wiley, 2007, pp. 153
37. Atik M. Dextran 40 and dextran 70: a review. Arch Surg 1967; 94: 664-672
38. Westphal M, James MF, Kozek-Langenecker S et al. Hydroxyethyl starches: different products-different effects. Anesthesiology 2009; 111: 187-202
39. Christidis C, Mal F, Ramos J et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol 2001; 35: 726-732
40. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008; 51: 491-503
41. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-699
42. Kamann S, Flaig MJ, Korting HC. Hydroxyethyl starch-induced itch: relevance of light microscopic analysis of semi-Thin sections and electron microscopy. J Dtsch Dermatol Ges 2007; 5: 204-208
43. Huter L, Simon TP, Weinmann L et al. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009; 13: R23
44. Finfer S, Bellomo R, Boyce N et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-2256
45. Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5% albumin infusions in cardiac surgical patients. Crit Care Med 2001; 29: 2299-2302
46. Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999; 27: 46-50
47. Nathan C, Xie QW, Halbwachs-Mecarelli L et al. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin). J Cell Biol 1993; 122: 243-256
48. Bignold LP, Rogers SD, Harkin DG. Effects of plasma proteins on the adhesion, spreading, polarization in suspension, random motility and chemotaxis of neutrophil leukocytes on polycarbonate (Nuclepore) filtration membrane. Eur J Cell Biol 1990; 53: 27-34
49. Horstick G, Lauterbach M, Kempf T et al. Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med 2002; 30: 851-855
50. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 1998; 317: 235-240
51. Maitland K, Kiguli S, Opoka RO et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364: 2483-2495
52. SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357: 874-884
53. SAFE Study InvestigatorsFinfer S, McEvoy S et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011; 37: 86-96
54. Roberts I, Blackhall K, Alderson P et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2011; 11: CD001208
55. Verheij J, Van Lingen A, Beishuizen A et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006; 32: 1030-1038
56. Trof RJ, Sukul SP, Twisk JW et al. Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med 2010; 36: 697-701
57. Lobo DN, Stanga Z, Aloysius MM et al. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010; 38: 464-470
58. Magder S, Potter BJ, Varennes BD et al. Canadian Critical Care Trials Group. Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids. Crit Care Med 2010; 38: 2117-2124
59. De Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001; 29: 1261-1267
60. Schortgen F, Lacherade JC, Bruneel F et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911-916
61. Schortgen F, Girou E, Deye N et al. CRYCO Study Group. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008; 34: 2157-2168
62. Rioux JP, Lessard M, De Bortoli B et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 2009; 37: 1293-1298
63. Perner A, Haase N, Guttormsen AB et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-134
64. Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139
65. Myburgh JA, Finfer S, Bellomo R et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-1911
66. Phillips DP, Kaynar AM, Kellum JA et al. Crystalloids vs colloids: KO at the twelfth round?. Crit Care 2013; 17: 319
67. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2: CD000567
68. Kruer RM, Ensor CR. Colloids in the intensive care unit. Am J Health Syst Pharm 2012; 69: 1635-1642
69. Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2013; 7: CD007594
70. Zarychanski R, Abou-Setta AM, Turgeon AF et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-Analysis. J Am Med Assoc 2013; 309: 678-688
71. Anonymous. Editors-in-Chief statement regarding published clinical trials conducted without IRB approval by Joachim Boldt. Minerva Anestesiol 2011; 77: 562-563
72. Miller DR. Update to readers and authors on ethical and scientific misconduct: retraction of the 'Boldt articles'. Can J Anaesth 2011; 58: 777-779, 779-781
73. Bayer O, Reinhart K, Sakr Y et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med 2011; 39: 1335-1342
74. Annane D, Siami S, Jaber S et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. J Am Med Assoc 2013; 310: 1809-1817
75. Stoneham MD, Hill EL. Variability in post-operative fluid and electrolyte prescription. Br J Clin Pract 1997; 51: 82-84
76. Greenfield RH, Bessen HA, Henneman PL. Effect of crystalloid infusion on hematocrit and intravascular volume in healthy, nonbleeding subjects. Ann Emerg Med 1989; 18: 51-55
77. Mullins RJ, Garrison RN. Fractional change in blood volume following normal saline infusion in high-risk patients before noncardiac surgery. Ann Surg 1989; 209: 651-659; discussion 659-661
78. Lobo DN, Stanga Z, Simpson JA et al. Dilution and redistribution effects of rapid 2-litre infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: a double-blind crossover study. Clin Sci(Lond) 2001; 101: 173-179
79. Reid F, Lobo DN, Williams RN et al. (Ab)normal saline and physiological Hartmann's solution: a randomized double-blind crossover study. Clin Sci(Lond) 2003; 104: 17-24
80. Hahn RG. Volume kinetics for infusion fluids. Anesthesiology 2010; 113: 470-481
81. Prough DS, White RT. Acidosis associated with perioperative saline administration: dilution or delusion?. Anesthesiology 2000; 93: 1167-1169
82. Garella S, Dana CL, Chazan JA. Severity of metabolic acidosis as a determinant of bicarbonate requirements. N Engl J Med 1973; 289: 121-126
83. Fernandez PC, Cohen RM, Feldman GM. The concept of bicarbonate distribution space: the crucial role of body buffers. Kidney Int 1989; 36: 747-752
84. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983; 61: 1444-1461
85. Kellum JA. Saline-induced hyperchloremic metabolic acidosis. Crit Care Med 2002; 30: 259-261
86. Vallet M, Picard N, Loffing-Cueni D et al. Pendrin regulation in mouse kidney primarily is chloride-dependent. J Am Soc Nephrol 2006; 17: 2153-2163
87. Frische S, Kwon TH, Frokiaer J et al. Regulated expression of pendrin in rat kidney in response to chronic NH4Cl or NaHCO3 loading. Am J Physiol Renal Physiol 2003; 284: F584-F593
88. Galla JH, Bonduris DN, Dumbauld SL et al. Segmental chloride and fluid handling during correction of chloride-depletion alkalosis without volume expansion in the rat. J Clin Invest 1984; 73: 96-106
89. Purkerson JM, Tsuruoka S, Suter DZ et al. Adaptation to metabolic acidosis and its recovery are associated with changes in anion exchanger distribution and expression in the cortical collecting duct. Kidney Int 2010; 78: 993-1005
90. Karet FE. Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol 2009; 20: 251-254
91. Julian BA, Galla JH, Guthrie GP, Jr et al. Renin and aldosterone responses to short-Term NaCl or NaHCO3 loading in man. J Lab Clin Med 1982; 100: 261-268
92. Williams EL, Hildebrand KL, McCormick SA et al. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999; 88: 999-1003
93. Scheingraber S, Rehm M, Sehmisch C et al. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999; 90: 1265-1270
94. McFarlane C, Lee A. A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anaesthesia 1994; 49: 779-781
95. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983; 71: 726-735
96. Quilley CP, Lin YS, McGiff JC. Chloride anion concentration as a determinant of renal vascular responsiveness to vasoconstrictor agents. Br J Pharmacol 1993; 108: 106-110
97. Chowdhury AH, Cox EF, Francis ST et al. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256: 18-24
98. Chowdhury AH, Cox EF, Francis ST et al. A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6% hydroxyethyl starch suspended in 0.9% saline (Voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2013; doi:10.1097/SLA.0000000000000324.
99. Greger R, Velazquez H. The cortical thick ascending limb and early distal convoluted tubule in the urinary concentrating mechanism. Kidney Int 1987; 31: 590-596
100. Imig JD, Passmore JC, Anderson GL et al. Chloride alters renal blood flow autoregulation in deoxycorticosterone-Treated rats. J Lab Clin Med 1993; 121: 608-613
101. Bullivant EM, Wilcox CS, Welch WJ. Intrarenal vasoconstriction during hyperchloremia: role of thromboxane. Am J Physiol 1989; 256: F152-F157
102. Zornow MH, Todd MM, Moore SS. The acute cerebral effects of changes in plasma osmolality and oncotic pressure. Anesthesiology 1987; 67: 936-941
103. Young JB, Utter GH, Schermer CR et al. Saline versus Plasma-Lyte a in initial resuscitation of trauma patients: a randomized trial. Ann Surg 2014; 259: 255-262.
104. Burdett E, Dushianthan A, Bennett-Guerrero E et al. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev 2012; 12: CD004089
105. Shaw AD, Bagshaw SM, Goldstein SL et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255: 821-829
106. Waters JH, Gottlieb A, Schoenwald P et al. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 2001; 93: 817-822
107. Hadimioglu N, Saadawy I, Saglam T et al. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg 2008; 107: 264-269
108. Khajavi MR, Etezadi F, Moharari RS et al. Effects of normal saline vs lactated ringer's during renal transplantation. Ren Fail 2008; 30: 535-539
109. Kim SY, Huh KH, Lee JR et al. Comparison of the effects of normal saline versus plasmalyte on acid-base balance during living donor kidney transplantation using the Stewart and base excess methods. Transplant Proc 2013; 45: 2191-2196
110. O'Malley CM, Frumento RJ, Hardy MA et al. A randomized, doubleblind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005; 100: 1518-1524, table of contents
111. Dikdan GS, Mora-Esteves C, Koneru B. Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues. Transplantation 2012; 94: 425-441
112. Rech TH, Moraes RB, Crispim D et al. Management of the brain-dead organ donor: a systematic review and meta-Analysis. Transplantation 2013; 95: 966-974
113. Yunos NM, Kim IB, Bellomo R et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med 2011; 39: 2419-2424
114. Yunos NM, Bellomo R, Hegarty C et al. Association between a chlorideliberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. J Am Med Assoc 2012; 308: 1566-1572
115. Mahler SA, Conrad SA, Wang H et al. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med 2011; 29: 670-674
116. Chua HR, Venkatesh B, Stachowski E et al. Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care 2012; 27: 138-145
117. Cieza JA, Hinostroza J, Huapaya JA et al. Sodium chloride 0.9% versus Lactated Ringer in the management of severely dehydrated patients with choleriform diarrhoea. J Infect Dev Ctries 2013; 7: 528-532